On June 29th, Yunnan Jianzhijia Health Chain Store Co., Ltd. (605266. SH (hereinafter referred to as "Healthy Home") announced that it had acquired 0/00% equity of Tangren Medicine/KLOC-for 2.074 billion yuan in cash, and took the latter's 659 directly-operated chain pharmacies in Hebei and Liaoning, which also set a new record for a single M&A transaction in the domestic pharmaceutical retail chain.
In recent years, with the gradual implementation of domestic regulatory policies, the pharmaceutical retail industry has ushered in earth-shaking changes. All major pharmaceutical retail chain enterprises want to seize a higher market share by "staking the land".
Jian Zhijia responded that through the acquisition of Tangren Medicine Project, the company can empower Tangren Medicine in terms of service professionalism, new retail and integrated marketing of goods. This transaction is the starting point for the company to expand to the whole country. After the transaction is completed, the company's business scale, number of stores, coverage area and market penetration rate will be greatly improved, which is conducive to improving the bargaining power and professional service ability of upstream suppliers, realizing the scale effect and synergy effect of professional promotion and commodity marketing services, reducing product procurement costs and stabilizing and improving profitability.
The People's Pharmacy said that the epidemic has interfered with the short-term performance growth of pharmacies, but in the long run, the trend of aging population and prescription outflow in China has not changed, and there is still huge room for development in the pharmaceutical retail industry. How to build the core competitiveness of enterprises and enhance market share will become the focus of enterprise development.
The pharmaceutical retail industry experienced negative growth.
IQVIA data shows that in the first quarter of 2022, the national retail pharmacy market scale was 202 1 100 million yuan, and the retail market experienced negative growth. MAT (rolling annual data) increased by-65,438+0.2%, down 2.65,438+0 percentage points from the previous quarter.
It is understood that since 20021,many places in the country have successively issued decisions to stop selling antipyretic, antitussive, antiviral and antibiotic drugs. The main sales channels of these four kinds of drugs are almost all chain pharmacies, which can even account for 13%~ 15% of the total income of chain pharmacies. IQVIA data shows that in the OTC and health care products market, cold and cough drugs are the largest category, accounting for 23.6% of the market share, but the growth rate dropped significantly, to -3.3%.
In the context of the overall negative growth of the pharmaceutical retail industry, two listed pharmaceutical retail enterprises have taken different measures to deal with the impact of the industry. At the same time, continuous mergers and acquisitions in the same industry have led to a rapid increase in the number of corporate stores, which has also driven the continuous growth of the revenue of the two companies.
The 20021annual report shows that Health Home has rapidly expanded its marketing network through self-construction and acquisition, and the store scale has grown rapidly. By the end of 20021,the total number of the company's stores had reached 3,044, with a net increase of 9 14 for the whole year and an increase of 42.9 1% compared with the beginning of the year. The company mentioned in the annual report that through the endogenous growth of old stores and sub-new stores and the expansion of physical sales network, the online and offline omni-channel sales revenue and supplier service revenue have grown steadily, and the scale has been improved. The company's operating income also increased by 65,438+07,438+0% compared with the previous period.
In view of the development trend of the industry, People's Pharmacy has adjusted and formulated enterprise management, business support, intelligent decision-making and core operation, including technology drive. Seize the opportunity of prescription outflow and seize the blue ocean market of prescription drugs; Embrace new retail and create a closed-loop ecology of "product+service+customer base"; March into the new countryside and build a three-dimensional expansion network; Expand the healthy social space for the elderly; Six strategies, such as the ODM model of the ultimate health product and the cultivation and growth of the own brand camp.
According to the data of the 20021annual report of Laobaixing Pharmacy, by the end of the reporting period, the chain layout network of Laobaixing Pharmacy has covered 20 provincial markets, 120 prefecture-level cities and more than 590 districts and counties in China, with 8,352 stores opened in * * *, and the company added 2160 stores in 2002/kloc-0. During the reporting period, the company's operating income increased by 12.38% compared with the previous year, mainly due to the growth of franchise business, the year-on-year growth of old retail stores and the contribution of new stores such as new opening and acquisition.
In May this year, the State Administration of Pharmaceutical Products issued the Regulations on the Implementation of the Drug Administration Law of People's Republic of China (PRC) (Revised Draft for Comment) (hereinafter referred to as the "Regulations"), stipulating that "third-party platform providers may not directly participate in online drug sales activities", which also involves the interest dispute between offline pharmacies and online platforms.
The two companies are also optimistic about the follow-up of this policy. Jian Zhijia said that third-party platforms are not allowed to participate in the supervision of drug retail, which is the only way under the strong supervision policy. Drug retailing has always been a strong regulatory industry. The implementation of this policy can further improve the standardized operation of market players and is conducive to the development of the company.
People's pharmacies believe that "third-party platform providers are not allowed to directly participate in online drug sales activities" mentioned in the implementation regulations, mainly to strengthen drug sales supervision and prevent the situation of "being both athletes and referees", which reflects the requirements of the state for the business norms of the drug retail industry. From this point of view, the formal promulgation of the "Implementation Regulations" is beneficial to leading pharmacies with higher operating standards.
Online and offline omni-channel * * * deposit trend
According to the data of Prospective Industry Research Institute, from the perspective of the proportion of different retail channels of drugs in China, offline pharmacy retail is still the mainstream. In 2020, offline pharmacy retail accounts for about 80.8%, followed by medical e-commerce accounts for about 13.8%, and DTP pharmacy retail (excluding online sales) only accounts for 5.4%.
In fact, under the increasingly fierce competition in the retail pharmacy market, promoting the omni-channel integration of "online+offline" has gradually become the future development direction of retail pharmacies.
It is understood that Jian Zhijia established the E-commerce Division after obtaining the Internet qualification certificate on 20 1 1, which is responsible for the cooperation between the operating company and third-party platforms such as Tmall, JD.COM and Vipshop. In 20 16, the company expanded its store SKU through its own O2O electronic shopping platform, providing customers with online booking, door-to-door pick-up or door-to-door delivery services; In 20 18, the company also established the O2O business unit to operate the third-party O2O business.
"The company has been focusing on new retail for more than 20 years, actively embracing the development of third-party platforms and forming a win-win situation with major platforms. At the same time, the company will continuously improve its professionalism, refine its procurement channels, and form a benign cooperative relationship with industrial enterprises through omni-channel cooperation. " Health, it is said.
The new retail business of People's Pharmacy is to establish a global marketing network of "O2O+B2C+ private domain" and maintain rapid growth.
According to the introduction of People's Pharmacy, in 20021year, the company achieved sales of nearly 700 million yuan through online channels, a year-on-year increase of 170%. By the end of the year, the company had 65,865,438+0O2O takeaway service stores, and the number of 24-hour stores increased to 448. In the first quarter of 2022, the company achieved sales of 270 million yuan through online channels, a year-on-year increase of 65,438+0.23%. The number of new members is 6.5438+0.68 million, and the number of active members is 9.54 million.
From the above point of view, leading chain pharmacies with more advantages in talent reserve, number of stores and upstream bargaining power can take the lead in the new retail business.
"Drugs are a special commodity. The timeliness of customers' drug purchase and the professionalism of drug guidance determine that O2O will be the main sector for the future development of pharmaceutical e-commerce, and online to offline cannot do without offline pharmacies as support. Online and offline omni-channel * * * integration will become the development trend of the industry, which is the advantage of the people's big pharmacy. "People's Pharmacy said that in the future, on the one hand, the company will take advantage of the extensive layout of offline stores and the service advantages of professional pharmacies for chronic disease management based on testing to do a good job in the community health flow entrance for home-based care. On the other hand, actively develop new retail business to meet customer needs in all directions.